Skip to main content

LCD L39810: Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)

LCD L39810, Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ), is the Local Coverage Determination that Noridian Healthcare Solutions, LLC applies to claims from 18 states (AK, AS, AZ, CA, CNMI, GU, HI, ID and others), effective 2025-10-23 and first in force 2025-04-17. The policy text runs 253 words, and its billing and coding article A59695 lists 19 ICD-10-CM codes that support medical necessity for 2 procedure codes. 2 other contractors publish a policy with the same title, so the criteria that apply depend on where the service is furnished.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database LCD export release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (Thursdays) for the MCD.
Contractor
Noridian Healthcare Solutions, LLC
States and territories
18
AK AS AZ CA CNMI GU HI ID MT ND NF NV OR SD SF UT WA WY
Revision effective
2025-10-23
Original effective
2025-04-17
Policy text
253 words
Covered ICD-10 codes (articles)
19

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L39810
ContractContractorTypeStates
03201Noridian Healthcare Solutions, LLCA and B MACMT
03301Noridian Healthcare Solutions, LLCA and B MACND
03401Noridian Healthcare Solutions, LLCA and B MACSD
03501Noridian Healthcare Solutions, LLCA and B MACUT
03601Noridian Healthcare Solutions, LLCA and B MACWY
03102Noridian Healthcare Solutions, LLCA and B MACAZ
03202Noridian Healthcare Solutions, LLCA and B MACMT
03302Noridian Healthcare Solutions, LLCA and B MACND
03502Noridian Healthcare Solutions, LLCA and B MACUT
03602Noridian Healthcare Solutions, LLCA and B MACWY
03402Noridian Healthcare Solutions, LLCA and B MACSD
03101Noridian Healthcare Solutions, LLCA and B MACAZ
02201Noridian Healthcare Solutions, LLCA and B MACID
02101Noridian Healthcare Solutions, LLCA and B MACAK
02301Noridian Healthcare Solutions, LLCA and B MACOR
02401Noridian Healthcare Solutions, LLCA and B MACWA
02202Noridian Healthcare Solutions, LLCA and B MACID
02102Noridian Healthcare Solutions, LLCA and B MACAK
02402Noridian Healthcare Solutions, LLCA and B MACWA
02302Noridian Healthcare Solutions, LLCA and B MACOR
01111Noridian Healthcare Solutions, LLCA and B MACCA
01211Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01311Noridian Healthcare Solutions, LLCA and B MACNV
01911Noridian Healthcare Solutions, LLCA and B MACAS CA CNMI GU HI NV
01112Noridian Healthcare Solutions, LLCA and B MACNF
01182Noridian Healthcare Solutions, LLCA and B MACSF
01212Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01312Noridian Healthcare Solutions, LLCA and B MACNV

Billing and coding: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A59695 (Billing and Coding: Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown.

A59695: Billing and Coding: Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (Billing and Coding, effective 2026-01-01)

Covered ICD-10-CM codes
19
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
2
Full article
cms.gov record
First 19 covered ICD-10-CM codes in A59695
ICD-10-CMDescription (FY2027)
M43.17—
M43.18—
M43.27—
M43.28—
M46.1—
M53.2X7—
M53.2X8—
M53.3—
M53.87—
M53.88—
M54.18—
M99.04—
M99.14—
S33.2XXA—
S33.2XXD—
S33.2XXS—
S33.6XXA—
S33.6XXD—
S33.6XXS—

Procedure codes: 27278, 27279.

Coverage indications, limitations and medical necessity

Covered Indications

• Minimally Invasive (MI) Arthrodesis of the sacroiliac joint (SIJ) WITH placement of a transfixation device is considered medically reasonable and necessary when ALL of the following criteria are met:

• Patient must meet all requirements for coverage as outlined in Sacroiliac Joint Injections and Procedures L39462 including:

• At least 1 diagnostic block with ≥75% reduction of pain as defined in L39462 AND

• A trial of at least 1 therapeutic intra-articular SIJ injection (i.e., corticosteroid injection that results in a ≥50% reduction of pain for the expected duration of the injected agent AND

• Diagnostic imaging studies that include ALL the following:

• Imaging (plain radiographs and a computed tomography (CT) or magnetic resonance imaging (MRI)) of the SIJ that excludes the presence of destructive lesions (e.g., tumor, infection), fracture, traumatic SIJ instability, or inflammatory arthropathy that would not be properly addressed by percutaneous SIJ fusion (SIJF)

• Imaging of the pelvis (anteroposterior (AP) plain radiograph) to rule out concomitant hip pathology

• Imaging of the lumbar spine (CT or MRI) to rule out neural compression or other degenerative condition that can be causing low back or buttock pain

• MI Arthrodesis of the SIJ WITHOUT placement of a transfixation device is NOT considered medically reasonable and necessary.

Limitations:

• Absence of generalized pain behavior (e.g., somatoform disorder) or generalized pain disorders (e.g., fibromyalgia)

• Patient should be part of an ongoing care plan, and be actively participating in a rehabilitation program, home exercise program or functional restoration program

Summary of evidence (opening)

The SIJ is a synovial or diarthrosis-amphiarthrosis joint, whose primary function is to transfer weight to and from the lower extremities to the axial skeleton. 1 The SIJ has been implicated as a source of chronic LBP in 15% to 30% of patients. 2 The SIJ contains both mechanoreceptors and nociceptive receptors such that SIJ pathology leads to pain in the buttocks, lower back, groin or leg. SIJ degeneration commonly occurs, especially after lumbar fusion. The SIJ is particularly enigmatic in its ability to mimic hip and lumbar spine pathology and also to result from the surgical treatment of hip and spine issues. 3 Patients with SIJ pain report Oswestry Disability Index (ODI) scores in the 50s and the burden of disease associated with SIJ pain is at least as high as that associated with other musculoskeletal conditions such as hip osteoarthritis, degenerative spondylolisthesis, or spinal stenosis; conditions that are often treated surgically. 4 Risk factors for SIJ dysfunction may include abnormal gait, scoliosis, degenerative and inflammatory arthritis, previous lumbar spinal surgery, trauma, and childbirth. 5 In addition, the SIJ may be a referred site of pain, including from a degenerative disc at L5-S1, spinal stenosis, or osteoarthritis of the hip.

Diagnosis remains problematic, with no universally accepted reference standard. Current best practice diagnostic techniques start with pain provocation testing. A positive result on 3 or more pain provocation tests, such as Gaenslen’s, FABER, compression, distraction, and thigh thrust, are used as criteria for further testing to confirm the SIJ as the primary pain generator. Typically, diagnostic blocks and intraarticular fluoroscopically guided injections are then used for confirmation of SIJ disorder. A standard of ≥75% relief of pain has been suggested as an indication of pain deriving from the SIJ. X-ray, CT or MRI of the SIJ has not proven to be sensitive or specific enough to be used alone but may be helpful when used in conjunction with other diagnostic techniques. Radiographic utility lies more in excluding the presence of other causes of pain that would not be properly addressed by percutaneous SIJF. 3,6,7

The mainstay of therapy for disorders of the SIJ has been nonoperative treatment, including activity modification, NSAIDs, physical therapy, radiofrequency neurotomy and SIJ injections (SIJIs). High quality clinical evidence corroborating the benefits of these non-surgical therapeutic options is limited by small patient populations, lack of placebo controls, and failure to utilize validated outcome measures. 8 When these modalities fail, the International Society for the Advancement of Spine Surgery (ISASS) recommends SIJ arthrodesis. 9 Surgical treatment is indicated for patients with a positive response to an SIJ injection with ≥75% relief, failure of nonsurgical treatment, and continued or recurrent SIJ pain.

Traditional open SIJF procedures are complex and invasive, involving open exposure of the joint with instrumented fixation and/or bone graft harvesting, and are typically associated with lengthy hospital stays, large blood loss and prolonged recovery times. Outcomes of traditional SIJF procedures were observed to be so poor with a high rate of reported non-union that these procedures were virtually abandoned over the last few decades. 10 However, in the case of revision surgery, nonunion, and aberrant anatomy, open arthrodesis should be performed. 11

The contractor cites 34 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2025-04-17
Current revision effective
2025-10-23
MCD version
13

Other related documents: A59961 (Response to Comments), A59962 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line, and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Noridian Healthcare Solutions, LLC hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

Frequently asked questions

What does LCD L39810 cover?

• Patient must meet all requirements for coverage as outlined in Sacroiliac Joint Injections and Procedures L39462 including: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database export of September 24, 2026.

Which states does LCD L39810 apply to?

Noridian Healthcare Solutions, LLC applies it to Medicare claims in AK, AS, AZ, CA, CNMI, GU, HI, ID, MT, ND, NF, NV, OR, SD, SF, UT, WA, WY. A Local Coverage Determination binds only the contractor that wrote it; the same service in another jurisdiction is judged under that contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L39810?

The companion billing and coding article A59695 lists 19 ICD-10-CM codes in 1 group that support medical necessity; the first 19 appear on this page and the complete list is in the article on cms.gov.

How do I appeal a denial under LCD L39810?

The remittance carries claim adjustment reason code 50 with remark code N115, naming the LCD. Compare the documented indication with the policy's covered indications and the article's diagnosis list, then file a redetermination within 120 days with the record attached; if the service genuinely falls outside the policy, the patient can be billed only when a valid Advance Beneficiary Notice was obtained before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.